78 participants
Busulfan & Melphalan Conditioning for Autologous Stem Cell Transplant (ASCT) and Lenalidomide Maintenance
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-06-05
- Start Date:
- 2013-10-01
- Completion:
- 2022-07-31
Conditions
- Multiple Myeloma
Interventions
- DRUG
No Results Yet